Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza Vaccines | 2 | 2020 | 2941 | 0.32 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2020 | 572 | 0.28 | Why? |
| B-Lymphocyte Subsets | 2 | 2020 | 372 | 0.23 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.21 | Why? |
| Mumps virus | 1 | 2019 | 15 | 0.20 | Why? |
| Lymphocyte Activation | 4 | 2021 | 2742 | 0.19 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.19 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.19 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.18 | Why? |
| Mumps | 1 | 2019 | 110 | 0.17 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.17 | Why? |
| Ferrets | 2 | 2020 | 1201 | 0.17 | Why? |
| Alphacoronavirus | 1 | 2021 | 392 | 0.15 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2020 | 511 | 0.15 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.15 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.14 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.14 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.12 | Why? |
| Disease Notification | 1 | 2019 | 639 | 0.12 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.11 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 6653 | 0.11 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Betacoronavirus | 5 | 2021 | 204454 | 0.08 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.07 | Why? |
| Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.07 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.07 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Neoplasms | 2 | 2021 | 17251 | 0.06 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.06 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 146 | 0.05 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.05 | Why? |
| Clonal Selection, Antigen-Mediated | 1 | 2020 | 45 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Adult | 10 | 2021 | 244371 | 0.05 | Why? |
| Leukopenia | 1 | 2021 | 280 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Philadelphia | 1 | 2020 | 454 | 0.05 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.05 | Why? |
| Eggs | 1 | 2018 | 43 | 0.05 | Why? |
| Cross Protection | 1 | 2021 | 373 | 0.05 | Why? |
| Lectins, C-Type | 1 | 2021 | 405 | 0.05 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.04 | Why? |
| Plasma Cells | 1 | 2020 | 464 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.04 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Animals | 3 | 2021 | 78931 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Molecular Sequence Data | 1 | 2019 | 3198 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.03 | Why? |
| Flow Cytometry | 1 | 2021 | 2393 | 0.03 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Phylogeny | 2 | 2019 | 13341 | 0.02 | Why? |
| Netherlands | 1 | 2019 | 3533 | 0.02 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.02 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| African Americans | 1 | 2020 | 3363 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
Gouma's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(115)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(210)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_